Hsa_circ_0032131 knockdown inhibits osteoarthritis progression via the miR-502-5p/PRDX3 axis

被引:13
|
作者
Xu, Jin [1 ]
Ma, Xinlong [1 ]
机构
[1] Tianjin Hosp, Dept Pain Treatment, Tianjin 300211, Peoples R China
来源
AGING-US | 2021年 / 13卷 / 11期
关键词
circRNA; OA; NF-KAPPA-B; MATRIX DEGRADATION; II COLLAGEN; CHONDROCYTES; APOPTOSIS; CARTILAGE; INFLAMMATION; EXPRESSION; AGGRECAN; SPONGE;
D O I
10.18632/aging.203073
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Osteoarthritis (OA) is a chronic disease characterized by progressive loss of cartilage and failure of the diarthrodial joint. Circular RNAs (circRNAs) are known to participate in the pathogenesis of multiple diseases, including OA. We investigated the functions of hsa_circ_0032131, a circRNA upregulated in OA, using CHON-001 cells and an in vivo OA rat model. CHON-001 cells were treated with interleukin (IL) -113 to mimic OA in vitro. IL 113 -induced inhibition of CHON-001 growth was reversed by silencing hsa_circ_0032131. In addition, hsa_circ_0032131 knockdown reversed IL-113 -induced activation of Trx1, Cyclin D and PRDX3, whereas overexpression of PRDX3, a direct target of miR-502-5p, reversed this effect. Hsa_circ_0032131 served as a competing endogenous RNA for miR-502-5p. Moreover, knockdown of hsa_circ_0032131 attenuated OA symptoms in vivo by inactivating the STAT3 signaling pathway. Thus, silencing of hsa_circ_0032131 inhibited the progression of OA by inactivating the miR-502-5p/PRDX3/Trx1/STAT3 axis, which highlights its potential as a therapeutic target for OA.
引用
收藏
页码:15100 / 15113
页数:14
相关论文
共 50 条
  • [21] Research Hsa_circ_0053063 inhibits breast cancer cell proliferation via hsa_circ_0053063/hsa-miR-330-3p/PDCD4 axis
    Ji, Changle
    Hu, Jiashu
    Wang, Xuehui
    Zheng, Wenfang
    Deng, Xiaochong
    Song, Hongming
    Yu, Yunhe
    Luo, Qifeng
    Hua, Kaiyao
    Zhou, Xiqian
    Fang, Lin
    AGING-US, 2021, 13 (07): : 9627 - 9645
  • [22] hsa_circ_0008234 inhibits the progression of lung adenocarcinoma by sponging miR-574-5p
    Jiang, Wei
    He, Yaozhou
    Ma, Zijian
    Zhang, Yu
    Zhang, Chengpeng
    Zheng, Nianpeng
    Tang, Xing
    CELL DEATH DISCOVERY, 2021, 7 (01)
  • [23] Hsa_circ_0008035 Knockdown Inhibits Bladder Cancer Progression through miR-1184/RAP2B Axis
    Fu, Yang
    Liu, Kun
    Jiang, Xi
    Zhao, Lun
    Wang, Tianwei
    UROLOGIA INTERNATIONALIS, 2023, 107 (06) : 632 - 645
  • [24] hsa_circ_0067514 suppresses gastric cancer progression and glycolysis via miR-654-3p/LATS2 axis
    Jiang, Shao-Feng
    Li, Rong-Rong
    NEOPLASMA, 2022, 69 (05) : 1079 - 1091
  • [25] hsa_circ_0000519 promotes the progression of lung adenocarcinoma through the hsa-miR-1296-5p/DARS axis
    Tu, Guangxu
    Peng, Weilin
    Peng, Xiong
    Zhao, Zhenyu
    Shi, Shuai
    Cai, Qidong
    He, Boxue
    Yin, Wei
    Peng, Shaoliang
    Wang, Li
    Yu, Fenglei
    Wang, Xiang
    AMERICAN JOURNAL OF CANCER RESEARCH, 2023, 13 (08): : 3342 - +
  • [26] Hsa_circ_0003159 inhibits gastric cancer progression by regulating miR-223-3p/NDRG1 axis
    Wang, Jingyu
    Lv, Weize
    Lin, Zhidong
    Wang, Xiao
    Bu, Juyuan
    Su, Yonghui
    CANCER CELL INTERNATIONAL, 2020, 20 (01)
  • [27] Hsa_circ_0003098 promotes bladder cancer progression via miR-377-5p/ ACAT2 axis
    Cheng, Yidong
    Yu, Hao
    Li, Kai
    Lv, Jiancheng
    Zhuang, Juntao
    Bai, Kexin
    Wu, Qikai
    Yang, Xiao
    Yang, Haiwei
    Lu, Qiang
    GENOMICS, 2023, 115 (05)
  • [28] Original Long non-coding RNA XIST contributes to osteoarthritis progression via miR-149-5p/DNMT3A axis
    Liu, Yunke
    Liu, Ke
    Tang, Chao
    Shi, Zuxuan
    Jing, Kai
    Zheng, Jia
    BIOMEDICINE & PHARMACOTHERAPY, 2020, 128
  • [29] Circular RNA hsa_circ_0012673 Promotes Breast Cancer Progression via miR-576-3p/SOX4 Axis
    Qiu, Xiangmei
    Zhang, Qiang
    Deng, Qingfang
    Li, Quan
    MOLECULAR BIOTECHNOLOGY, 2023, 65 (01) : 61 - 71
  • [30] Hsa_circ_0000285 knockdown inhibits the progression of hepatocellular carcinoma by sponging miR-582-3p to regulate CCNB2 expression
    Huang, Jing
    Zhou, Hongchi
    Diao, Yun
    Yang, Zhiming
    HUMAN & EXPERIMENTAL TOXICOLOGY, 2022, 41